| Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride. | |
| | |
MedLine Citation:
|
PMID: 3514609 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cultured human melanoma M21 cells were treated with diethylcarbamazine (DEC), an inhibitor of proteoglycan biosynthesis in rat chondrosarcoma cells, to examine the assembly and transport of a chondroitin sulfate proteoglycan to the plasma membrane. Pretreatment of melanoma cells at 37 degrees C for 15 min with increasing doses of DEC followed by a 60-min pulse with [35S]sulfate in the presence of DEC resulted in a dose-related inhibition of incorporation of [35S]sulfate into macromolecules. In cells incubated for 75 min with both 1 mM beta-D-xyloside and 15 mM DEC, synthesis and secretion of beta-D-xyloside-bound 35S-glycosaminoglycans were inhibited by more than 80% as compared to cells treated with beta-D-xyloside alone; this inhibition was reversible. As assessed by [3H]serine incorporation into protein, overall protein synthesis was not substantially inhibited by DEC treatment. Detergent lysates from [35S]methionine-labeled melanoma cells were incubated with a monoclonal antibody (9.2.27) that specifically recognizes the peptide core of the melanoma proteoglycan. As assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the immunoprecipitate, a 240,000 Mr endoglycosidase H (Endo-H)-sensitive intermediate was the only form of the proteoglycan present inside the cells when the cultures were treated for 60-120 min with 10-15 mM DEC. When the melanoma cells were incubated for 10 min with 15 mM DEC and 100 mu Ci/ml of [35S]methionine, washed, and then chased for 15 min to 4 h in radioactive-free medium, the 240,000 Mr Endo-H-sensitive intermediate was slowly converted to a 250,000 Endo-H-resistant intermediate but not to a mature proteoglycan molecule that possessed chondroitin sulfate glycosaminoglycans. SDS-PAGE analysis of cell surface immunoprecipitates revealed that only a small amount of the 250,000 Mr intermediate was transported to the plasma membrane within 5 h of incubation in the presence of DEC. Proteoglycan synthesis was also inhibited when the melanoma cells were incubated for 60-120 min with ammonium chloride, but unlike DEC-treated cells the majority of the synthesized peptide core was converted to a 245,000 Mr Endo-H-resistant intermediate that was detected on the cell surface. Light and electron microscopic analysis of DEC-treated melanoma cells revealed large vacuoles and a distended Golgi and endoplasmic reticulum. Ammonium chloride-treated cells contained fewer vacuoles than DEC-treated cells but more vacuoles than normal cells.(ABSTRACT TRUNCATED AT 400 WORDS) |
| | |
Authors:
|
R C Spiro; W G Parsons; S K Perry; J P Caulfield; A Hein; R A Reisfeld; J R Harper; K F Austen; R L Stevens |
Related Documents
:
|
17947299 - Sodium-potassium atpase 1 subunit is a molecular partner of wolframin, an endoplasmic r... 8852949 - Tgf-beta and basement membrane matrigel stimulate the chondrogenic phenotype in osteobl... 10862739 - (beta)-catenin mediates the specification of endoderm cells in ascidian embryos. 20699059 - α- and β-poly(vinylidene fluoride) evoke different cellular behaviours. 8993839 - Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in p... 17563059 - Normal relationship of beta- and non-beta-cells not needed for successful islet transpl... 9486799 - Balancing division and expansion during maize leaf morphogenesis: analysis of the mutan... 2211839 - Effects of differentiation-inducing agents on maturation of human mcf-7 breast cancer c... 21167829 - Triptolide inhibits rat vascular smooth muscle cell proliferation and cell cycle progre... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 261 ISSN: 0021-9258 ISO Abbreviation: J. Biol. Chem. Publication Date: 1986 Apr |
Date Detail:
|
Created Date: 1986-05-14 Completed Date: 1986-05-14 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 5121-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Ammonium Chloride
/
pharmacology* Cell Line Diethylcarbamazine / pharmacology* Disaccharides / analysis Exocytosis / drug effects Glycosaminoglycans / metabolism Glycosides / pharmacology Humans Immunosorbent Techniques Melanoma / metabolism*, ultrastructure Microscopy, Electron Molecular Weight Protein Processing, Post-Translational / drug effects* Proteochondroitin Sulfates / metabolism* Proteoglycans / metabolism* Sulfates / metabolism Sulfur Radioisotopes |
| Grant Support | |
ID/Acronym/Agency:
|
AI-22531/AI/NIAID NIH HHS; AI-23401/AI/NIAID NIH HHS; AM-35984/AM/NIADDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Disaccharides; 0/Glycosaminoglycans; 0/Glycosides; 0/Proteochondroitin Sulfates; 0/Proteoglycans; 0/Sulfates; 0/Sulfur Radioisotopes; 0/xylosides; 12125-02-9/Ammonium Chloride; 90-89-1/Diethylcarbamazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Altered kinetic properties of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase following di...
Next Document: Structures of glycosphingolipids isolated from human embryonal carcinoma cells. The presence of mono...